title: [Subcutaneous immunoglobulin and support program: what level of interest of patients?].
abstract: Two different routes of administration exist for the immunoglobulin therapy: intravenous (Ig IV - monthly administration in medical setting) and subcutaneous (Ig SC - weekly self-administration at home). According to the literature, efficacy and safety are similar,. but Ig SC could improve quality of life and treatment satisfaction. The Policlinique Médicale Universitaire of Lausanne has developed an interdisciplinary program for the long-term support of Ig SC patients. Moreover, it conducted an exploratory survey interviewing Ig IV patients about their interest for Ig SC: patients interested judged less favourably efficacy and/or tolerance of Ig IV and considered that Ig SC would improve their motivation for treatment and its impact on their private and professional life.
authors.forename: A
authors.initials: A
authors.lastname: Bourdin
authors.forename: J
authors.initials: J
authors.lastname: Berger
authors.forename: A
authors.initials: A
authors.lastname: Früh
authors.forename: F
authors.initials: F
authors.lastname: Spertini
authors.forename: O
authors.initials: O
authors.lastname: Bugnon
mesh_terms: D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage* / Q000009:adverse effects; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage* / Q000009:adverse effects; D007279:Injections, Subcutaneous; D017060:Patient Satisfaction; D011788:Quality of Life; D012646:Self Administration
chemical_list: D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous